top of page


FDA Approved: New Long-Acting PrEP Regimen and Its Implications
In June 2025, the US Food and Drug Administration approved a new HIV pre-exposure prophylaxis (PrEP) regimen: the long-acting injectable...
19 hours ago30 min read
0 views
0 comments


Building Global Power: A National Strategy for Deeptech Health Startups in Brazil
The emergence of cutting-edge technologies, known as deeptechs, marks a new phase in global innovation. These technologies, which emerge...
Jun 633 min read
5 views
0 comments


Beyond Borders: Internationalization Strategies for Health Startups
In recent years, I’ve had the privilege of closely following the birth and growth of dozens of health startups, both in Brazil and...
Apr 73 min read
1 view
0 comments


Microbiome and Global Health: Exploring New Frontiers in Biotechnology
Throughout my career as an executive, consultant, and entrepreneur in healthcare, I have always sought to connect science, innovation,...
Mar 306 min read
1 view
0 comments


Only 10% of Brazilian Invention Patents Originate in Brazil: What Does This Mean for Our Sovereignty?
Technological innovation is a fundamental factor for a country’s economic development and competitiveness. In Brazil, intellectual...
Mar 94 min read
3 views
0 comments


The Construction of Innovation Ecosystems as a National Strategy: The Case of Health
In the contemporary global landscape, the concept of an isolated national economy has become a fiction. Nations do not compete solely for...
Feb 206 min read
1 view
0 comments


Exploring the Potential of Brazilian Biodiversity in Health
Brazil’s biodiversity, widely recognized as one of the richest in the world, offers a window of opportunity for innovative health...
Jan 264 min read
9 views
6 comments


The global Alzheimer's market in transformation: innovations and impacts in Brazil
The global Alzheimer’s market is undergoing a significant transformation. According to GlobalData , this market is expected to reach...
Jan 203 min read
6 views
0 comments


The Importance of Regulatory Agencies in Health Innovation and Pharmaceutical Regulation: FDA, EMA, and ANVISA in Perspective
Health innovation and the remarkable growth of the pharmaceutical sector—with a projected global revenue of USD 1.155 trillion in...
Nov 1, 20244 min read
2 views
0 comments
bottom of page